Concepedia

Publication | Closed Access

An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study

107

Citations

34

References

2013

Year

Abstract

Statistically significant and clinically relevant improvements in weight loss and health outcomes were observed with the IGBG at 6 months versus behavioral modification alone. The differential weight loss was still evident 6 months after IGB removal.

References

YearCitations

Page 1